An acute decrease in serum potassium levels causes what effect on neuromuscular blockade?

An acute decrease in serum potassium levels causes what effect on neuromuscular blockade?

• A. No effect with any relaxants
• B. Resistance to both depolarizing and nondepolarizing
• C. Increased sensitivity to both depolarizing and nondepolarizing
• D. Resistance to depolarizing and increased sensitivity to nondepolarizing

Answer: (D)

When potassium in the blood falls, the muscle end-plate becomes more hyperpolarized due to the larger gradient for potassium to leave the cell. A more negative resting membrane potential makes it harder for the end-plate to reach the threshold needed to fire an action potential. This shifts how different neuromuscular blockers behave. Depolarizing agents, which work by keeping the nicotinic receptor channels open and causing sustained depolarization, rely on the end-plate’s ability to be driven toward and maintained in a depolarized state. If the end-plate is more hyperpolarized, it resists depolarization, so the effect of the depolarizing blocker is blunted — you see resistance to this type of block. Nondepolarizing agents, on the other hand, block the receptor competitively, preventing acetylcholine from activating the receptor. In a hypoactive, more hyperpolarized end-plate, even a standard amount of receptor blockade has a greater impact on transmission, so there is increased sensitivity to nondepolarizing blockers. Clinically, acute hypokalemia means you’d expect reduced effectiveness of depolarizing blockers and heightened sensitivity to nondepolarizing blockers, which is why the correct pattern is resistance to depolarizing with increased sensitivity to nondepolarizing agents.

When potassium in the blood falls, the muscle end-plate becomes more hyperpolarized due to the larger gradient for potassium to leave the cell. A more negative resting membrane potential makes it harder for the end-plate to reach the threshold needed to fire an action potential. This shifts how different neuromuscular blockers behave.

Depolarizing agents, which work by keeping the nicotinic receptor channels open and causing sustained depolarization, rely on the end-plate’s ability to be driven toward and maintained in a depolarized state. If the end-plate is more hyperpolarized, it resists depolarization, so the effect of the depolarizing blocker is blunted — you see resistance to this type of block.

Nondepolarizing agents, on the other hand, block the receptor competitively, preventing acetylcholine from activating the receptor. In a hypoactive, more hyperpolarized end-plate, even a standard amount of receptor blockade has a greater impact on transmission, so there is increased sensitivity to nondepolarizing blockers.

Clinically, acute hypokalemia means you’d expect reduced effectiveness of depolarizing blockers and heightened sensitivity to nondepolarizing blockers, which is why the correct pattern is resistance to depolarizing with increased sensitivity to nondepolarizing agents.